These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 29664028)
1. Dyslipidaemia & oxidative stress in patients of psoriasis: Emerging cardiovascular risk factors. Asha K; Singal A; Sharma SB; Arora VK; Aggarwal A Indian J Med Res; 2017 Dec; 146(6):708-713. PubMed ID: 29664028 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of the atherogenic tendency of lipids and lipoprotein content and their relationships with oxidant-antioxidant system in patients with psoriasis. Vanizor Kural B; Orem A; Cimşit G; Yandi YE; Calapoglu M Clin Chim Acta; 2003 Feb; 328(1-2):71-82. PubMed ID: 12559600 [TBL] [Abstract][Full Text] [Related]
3. Comprehensive lipid tetrad index, atherogenic index and lipid peroxidation: Surrogate markers for increased cardiovascular risk in psoriasis. Sunitha S; Rajappa M; Thappa DM; Chandrashekar L; Munisamy M; Revathy G; Priyadarssini M Indian J Dermatol Venereol Leprol; 2015; 81(5):464-71. PubMed ID: 26323680 [TBL] [Abstract][Full Text] [Related]
4. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study. Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617 [TBL] [Abstract][Full Text] [Related]
5. The evaluation of autoantibodies against oxidatively modified low-density lipoprotein (LDL), susceptibility of LDL to oxidation, serum lipids and lipid hydroperoxide levels, total antioxidant status, antioxidant enzyme activities, and endothelial dysfunction in patients with Behçet's disease. Orem A; Yandi YE; Vanizor B; Cimşit G; Uydu HA; Malkoç M Clin Biochem; 2002 May; 35(3):217-24. PubMed ID: 12074830 [TBL] [Abstract][Full Text] [Related]
6. Oxidized low-density lipoprotein (oxLDL) plasma levels and oxLDL to LDL ratio - are they real oxidative stress markers in dialyzed patients? Pawlak K; Mysliwiec M; Pawlak D Life Sci; 2013 Mar; 92(4-5):253-8. PubMed ID: 23295961 [TBL] [Abstract][Full Text] [Related]
7. Age-related modification of antioxidant enzyme activities in relation to cardiovascular risk factors. Fabian E; Bogner M; Elmadfa I Eur J Clin Invest; 2012 Jan; 42(1):42-8. PubMed ID: 21722101 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of Oxidative Stress Parameters and Antioxidant Status in Coronary Artery Disease Patients. Varadhan S; Venkatachalam R; Perumal SM; Ayyamkulamkara SS Arch Razi Inst; 2022 Apr; 77(2):853-859. PubMed ID: 36284944 [TBL] [Abstract][Full Text] [Related]
9. Lipid peroxidation markers in Crohn's disease: the associations and diagnostic value. Boehm D; Krzystek-Korpacka M; Neubauer K; Matusiewicz M; Paradowski L; Gamian A Clin Chem Lab Med; 2012 Mar; 50(8):1359-66. PubMed ID: 22868800 [TBL] [Abstract][Full Text] [Related]
10. The relationships between exogenous and endogenous antioxidants with the lipid profile and oxidative damage in hemodialysis patients. Roehrs M; Valentini J; Paniz C; Moro A; Charão M; Bulcão R; Freitas F; Brucker N; Duarte M; Leal M; Burg G; Grune T; Garcia SC BMC Nephrol; 2011 Oct; 12():59. PubMed ID: 22029620 [TBL] [Abstract][Full Text] [Related]
11. Impact of adalimumab treatment on cardiovascular risk biomarkers in psoriasis: Results of a pilot study. Gkalpakiotis S; Arenbergerova M; Gkalpakioti P; Potockova J; Arenberger P; Kraml P J Dermatol; 2017 Apr; 44(4):363-369. PubMed ID: 27774694 [TBL] [Abstract][Full Text] [Related]
12. Plasma lipid peroxidation and totalantioxidant status among dyslipidaemic and hypertensive Nigerians with high risk of coronary heart disease. Ogunro PS; Balogun WO; Fadero FF; Idogun ES; Oninla SO; Elemile PO; Eziyi AK West Afr J Med; 2009 Mar; 28(2):87-91. PubMed ID: 19761169 [TBL] [Abstract][Full Text] [Related]
13. Changes in blood lipid peroxidation markers and antioxidants after a single sprint anaerobic exercise. Groussard C; Rannou-Bekono F; Machefer G; Chevanne M; Vincent S; Sergent O; Cillard J; Gratas-Delamarche A Eur J Appl Physiol; 2003 Mar; 89(1):14-20. PubMed ID: 12627300 [TBL] [Abstract][Full Text] [Related]
14. Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism. Torun AN; Kulaksizoglu S; Kulaksizoglu M; Pamuk BO; Isbilen E; Tutuncu NB Clin Endocrinol (Oxf); 2009 Mar; 70(3):469-74. PubMed ID: 18727709 [TBL] [Abstract][Full Text] [Related]
16. High oxidative stress in patients with stable coronary heart disease. Weinbrenner T; Cladellas M; Isabel Covas M; Fitó M; Tomás M; Sentí M; Bruguera J; Marrugat J Atherosclerosis; 2003 May; 168(1):99-106. PubMed ID: 12732392 [TBL] [Abstract][Full Text] [Related]
18. The levels of adiponectin and leptin and their relation to other markers of cardiovascular risk in patients with psoriasis. Kaur S; Zilmer K; Leping V; Zilmer M J Eur Acad Dermatol Venereol; 2011 Nov; 25(11):1328-33. PubMed ID: 21349112 [TBL] [Abstract][Full Text] [Related]
19. Relationship between severity of adult community-acquired pneumonia and impairment of the antioxidant defense system. Castillo RL; Carrasco RA; Alvarez PI; Ruiz M; Luchsinger V; Zunino E; Martínez MA; Avendaño LF Biol Res; 2013; 46(2):207-13. PubMed ID: 23959020 [TBL] [Abstract][Full Text] [Related]
20. The correlation between markers of oxidative stress and risk factors of coronary artery disease in Thai patients. Tosukhowong P; Sangwatanaroj S; Jatuporn S; Prapunwattana P; Saengsiri A; Rattanapruks S; Srimahachota S; Udayachalerm W; Tangkijvanich P Clin Hemorheol Microcirc; 2003; 29(3-4):321-9. PubMed ID: 14724357 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]